Sandbox vidit2: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{familytree/start |style=font-size:85%; line-height: 120%; |summary=PE diagnosis Algorithm.}} {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | |..." |
No edit summary |
||
Line 1: | Line 1: | ||
===General Management=== | |||
{{familytree/start |style=font-size:85%; line-height: 120%; |summary=PE diagnosis Algorithm.}} | {{familytree/start |style=font-size:85%; line-height: 120%; |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | | | | | | | | |A01=Continuous monitoring under quite environment w/ preventive treatment strategies}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | | | | | | | | |A01=Continuous monitoring under quite environment w/ preventive treatment strategies}} | ||
Line 7: | Line 8: | ||
{{familytree | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| |}} | {{familytree | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| |}} | ||
{{familytree | C01 | | | C02 | | | C03 | | | C04 | | | C05 | | | C06 | | | C07 | | | C08 | | | C09 | | | C10 | | | C11 |C01=*Monitor ICP, CPP & cerebral oxygenation<BR>*Elevate head end to 30°<BR>*Monitor fluid status<BR>*3% NS<BR>*Avoid NGT and suction|C02=*Platelet count & coagulation profile (12th hourly)<BR>*Inj. Vit. K<BR>*Cryoprecipitate|C03=*Discontinue medications<BR>*Avoid nephrotoxic & hepatotoxic drugs|C04=*Ranitidine|C05=*Monitor CVP w/ central venous catheter|C06=*Frequent monitoring of mental status|C07=*CBC (12th hourly)<BR>*CXR; sputum, blood & urine cultures (daily)<BR>*Cefotaxime, meropenem, fluconazole or vancomycin|C08=*Serum BCH, ABG, lactate (12th hourly)<BR>*Serum glucose (2nd hourly)|C09=*NAC (i.v × 2d then P.O.)|C10=*Eternal feeding<BR>*Parental feeding|C11=*Urinary I/O}} | {{familytree | C01 | | | C02 | | | C03 | | | C04 | | | C05 | | | C06 | | | C07 | | | C08 | | | C09 | | | C10 | | | C11 |C01=*Monitor ICP, CPP & cerebral oxygenation<BR>*Elevate head end to 30°<BR>*Monitor fluid status<BR>*3% NS<BR>*Avoid NGT and suction|C02=*Platelet count & coagulation profile (12th hourly)<BR>*Inj. Vit. K<BR>*Cryoprecipitate|C03=*Discontinue medications<BR>*Avoid nephrotoxic & hepatotoxic drugs|C04=*Ranitidine|C05=*Monitor CVP w/ central venous catheter|C06=*Frequent monitoring of mental status|C07=*CBC (12th hourly)<BR>*CXR; sputum, blood & urine cultures (daily)<BR>*Cefotaxime, meropenem, fluconazole or vancomycin|C08=*Serum BCH, ABG, lactate (12th hourly)<BR>*Serum glucose (2nd hourly)|C09=*NAC (i.v × 2d then P.O.)|C10=*Eternal feeding<BR>*Parental feeding|C11=*Urinary I/O}} | ||
{{familytree/end}} | |||
===Etiology Specific Management=== | |||
{{familytree/start |style=font-size:80%; line-height: 120%;| summary=Etiology specific alogorithm}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | | | | | | | | |A01=Etiology specific management}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}} | |||
{{familytree | |,|-|-|-|-|v|-|-|-|-|v|-|-|-|-|v|-|-|-|-|v|-|-|-|-|+|-|-|-|-|v|-|-|-|-|v|-|-|-|-|v|-|-|-|-|v|-|-|-|-|.| |}} | |||
{{familytree | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| |}} | |||
{{familytree | B01 | | | B02 | | | B03 | | | B04 | | | B05 | | | B06 | | | B07 | | | B08 | | | B09 | | | B10 | | | B11 |B01=*H/o acetaminophen intake<BR>*Consider if no H/o but elevated aminotransferase (>3500 IU/L)|B02=*Jaundice, coagulopathy, thrombocytopenia ± hypoglycemia<BR>*Hypertension & proteinuria<BR>*+ Steatosis during liver imaging or biopsy|B03=*Elevated aminotransferase responding to fluid resuscitation<BR>*Associated renal dysfunction & muscle necrosis|B04=*+ Serum autoantibodies<BR>*+ Liver biopsy|B05=*Abdominal pain, ascites and hepatomegaly<BR>*+ Liver imaging (CT/MRV/venogram/doppler USG)|B06=*H/o hepatotoxic drug intake (<6m)<BR>*Unlikely if H/o intake >1 or 2 years|B07=*Massive hepatomegaly<BR>*+ Liver imaging & biopsy|B08=*H/o mushroom intake<BR>*Suspect if no H/o but severe GI Sx (NVD)|B09=*+ Hepatitis serology<BR>*+ Liver biopsy for HSV<BR>|B10=*Serum bilirubin >20g/dL, bilirubin:alkaline phosphatase >2.0, low serum ceruloplasmin, elevated serum & urine copper, + KF ring, + liver biopsy|B11=Etiology undetermined}} | |||
{{familytree | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| |}} | |||
{{familytree | C01 | | | C02 | | | C03 | | | C04 | | | C05 | | | C06 | | | C07 | | | C08 | | | C09 | | | C10 | | | C11 |C01=Acetaminophen toxicity|C02=Acute fatty liver of pregnancy/HELLP|C03=Acute ischemic injury|C04=Autoimmune|C05=Budd-Chiari|C06=Drug induced|C07=Malignant infiltration|C08=Mushroom poisoning|C09=Viral|C10=Wilson's disease|C11=Intermediate etiology}} | |||
{{familytree | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| |}} | |||
{{familytree | D01 | | | D02 | | | D03 | | | D04 | | | D05 | | | D06 | | | D07 | | | D08 | | | D09 | | | D10 | | | D11 |D01=*Activated charcoal<BR>*NAC|D02=*Deliver immediately|D03=*Manage the cause of ischemia|D04=*Prednisolone<BR>*Transplantation|D05=*Transplantation|D06=*Discontinue all possible medications except essential drugs|D07=*Supportive Rx|D08=*Activated charcoal & gastric lavage<BR>*Penicillin G or Silibinin<BR>*Fluid resuscitation|D09=*Supportive Rx<BR>*Lamivudine or adefovir<BR>*Acyclovir|D10=*Dialysis or hemofiltration or plasmapheresis or plasma exchange<BR>*Transplantation|D11=*Incomplete drug or toxin intake H/O<BR>*Transjugular biopsy to R/O mailgnancy, Wilson's disease, autoimmune hepatitis or viral hepatitis}} | |||
{{familytree/end}} | |||
===Complication Specific Management=== | |||
{{familytree/start |style=font-size:85%; line-height: 120%; | summary=PE diagnosis Algorithm.}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | | | | | | | | |A01=Complication specific management}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | |,|-|-|-|-|v|-|-|-|-|v|-|-|-|-|+|-|-|-|-|v|-|-|-|-|v|-|-|-|-|.| |}} | |||
{{familytree | | | | | | | | | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| |}} | |||
{{familytree | | | | | | | | | | | B01 | | | B02 | | | B03 | | | B04 | | | B05 | | | B06 | | | B07 |B01=Ascites|B02=Cerebral edema & increased ICP|B03=Coagulopathy|B04=Hemodynamic instability|B05=Hepatic encephalopathy|B06=Metabolic disturbances|B07=Renal failure}} | |||
{{familytree | | | | | | | | | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | |!| | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | C01 | | | C02 | | | C03 | | | C04 | | | C05 | | | C06 | | | C07 |C01=Therapeutic paracentesis w/ 25% albumin<BR><br> <3 mEq/Kg of Na daily<BR><br> Lasix & aldactone|C02=ICP >25 mmHg|C03=+ Bleeding or prior to surgery|C04=Colloid, dextrose in crystalloid (if hypoglycemic) & 1/2 NS w/ 75 mg/L HCO3 (if acidotic)<BR><br> Norepinephrine±vasopressin<BR><br> Hydrocortisone|C05=Grade|C06=Rx acidosis, alkalosis, hypophosphatemia, hypomagnesemia, hypokalemia or hypoglycemia accordingly|C07=Continuous venovenous hemodialysis}} | |||
{{familytree | | | | | | | | | | | | | | | | |!| | | | |!| | | | | |,|-|-|-|+|-|-|-|.| | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | D01 | | | D02 | | | | D03 | | D04 | | D05 | | | | | | | | | | | | | | |D01=SpO2|D02=Platelet transfusion (if ≤50,000/mm2)<BR><br> FFP /+ rFVIIa (if INR≥1.5)|D03=I|D04=II|D05=III/IV}} | |||
{{familytree | | | | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | |!| | | |!| | | |!| | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | E01 | | | | | | | | | | | | E02 | | E03 | | E04 | | E05 | | | | | | | | | | | | | | | | |E01= <80 |E02= >80 |E03= 2nd hourly monitoring in quiet environment in high dependency ward|E04=ICU management<BR><br> Stat CT to R/O ICH<BR><br> Short acting BZD<BR><br> Lactulose|E05=ICU management<BR><br> Intubation & mechanical ventilation<BR><br> Propofol<BR><br> Elevate head end to 30°<BR><br> Quiet environment monitoring for CVP, hemodynamic & renal parameters, serum electrolytes, acid base status & neurological status}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | |!| | | |!| | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | F01 |-|-|-|-| F02 |-|-|-|-| F03 | | F04 | | | | | | | | | | | | | | | | | | | | | | |F01=20% mannitol|F02=No improvement|F03=Hyperventillation|F04=Worsening}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | G01 | | | | | | | | | | | | | | | | G02 | | | | | | | | | | | | | | | | | | | | | | | |G01=3% NS|G02=Transfer to ICU}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | H01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |H01=Reduce core temperature to 32°-34° (monitor for arrhythmias)}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | I01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |I01=Thiopental 125 mg i.v bolus}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | J01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |J01=Improvement or refractory}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | K01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |K01=Transplantation}} | |||
{{familytree/end}} |
Revision as of 18:39, 9 December 2013
General Management
Continuous monitoring under quite environment w/ preventive treatment strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cerebral edema & increased ICP | Coagulopathy | Drugs | GI bleeding | Hemodynamic instability | Hepatic encephalopathy | Infections | Metabolic disturbances | NAC | Nutritional deficiency | Renal failure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Monitor ICP, CPP & cerebral oxygenation *Elevate head end to 30° *Monitor fluid status *3% NS *Avoid NGT and suction | *Platelet count & coagulation profile (12th hourly) *Inj. Vit. K *Cryoprecipitate | *Discontinue medications *Avoid nephrotoxic & hepatotoxic drugs | *Ranitidine | *Monitor CVP w/ central venous catheter | *Frequent monitoring of mental status | *CBC (12th hourly) *CXR; sputum, blood & urine cultures (daily) *Cefotaxime, meropenem, fluconazole or vancomycin | *Serum BCH, ABG, lactate (12th hourly) *Serum glucose (2nd hourly) | *NAC (i.v × 2d then P.O.) | *Eternal feeding *Parental feeding | *Urinary I/O | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Etiology Specific Management
Etiology specific management | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*H/o acetaminophen intake *Consider if no H/o but elevated aminotransferase (>3500 IU/L) | *Jaundice, coagulopathy, thrombocytopenia ± hypoglycemia *Hypertension & proteinuria *+ Steatosis during liver imaging or biopsy | *Elevated aminotransferase responding to fluid resuscitation *Associated renal dysfunction & muscle necrosis | *+ Serum autoantibodies *+ Liver biopsy | *Abdominal pain, ascites and hepatomegaly *+ Liver imaging (CT/MRV/venogram/doppler USG) | *H/o hepatotoxic drug intake (<6m) *Unlikely if H/o intake >1 or 2 years | *Massive hepatomegaly *+ Liver imaging & biopsy | *H/o mushroom intake *Suspect if no H/o but severe GI Sx (NVD) | *+ Hepatitis serology *+ Liver biopsy for HSV | *Serum bilirubin >20g/dL, bilirubin:alkaline phosphatase >2.0, low serum ceruloplasmin, elevated serum & urine copper, + KF ring, + liver biopsy | Etiology undetermined | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acetaminophen toxicity | Acute fatty liver of pregnancy/HELLP | Acute ischemic injury | Autoimmune | Budd-Chiari | Drug induced | Malignant infiltration | Mushroom poisoning | Viral | Wilson's disease | Intermediate etiology | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Activated charcoal *NAC | *Deliver immediately | *Manage the cause of ischemia | *Prednisolone *Transplantation | *Transplantation | *Discontinue all possible medications except essential drugs | *Supportive Rx | *Activated charcoal & gastric lavage *Penicillin G or Silibinin *Fluid resuscitation | *Supportive Rx *Lamivudine or adefovir *Acyclovir | *Dialysis or hemofiltration or plasmapheresis or plasma exchange *Transplantation | *Incomplete drug or toxin intake H/O *Transjugular biopsy to R/O mailgnancy, Wilson's disease, autoimmune hepatitis or viral hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Complication Specific Management
Complication specific management | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ascites | Cerebral edema & increased ICP | Coagulopathy | Hemodynamic instability | Hepatic encephalopathy | Metabolic disturbances | Renal failure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Therapeutic paracentesis w/ 25% albumin <3 mEq/Kg of Na daily Lasix & aldactone | ICP >25 mmHg | + Bleeding or prior to surgery | Colloid, dextrose in crystalloid (if hypoglycemic) & 1/2 NS w/ 75 mg/L HCO3 (if acidotic) Norepinephrine±vasopressin Hydrocortisone | Grade | Rx acidosis, alkalosis, hypophosphatemia, hypomagnesemia, hypokalemia or hypoglycemia accordingly | Continuous venovenous hemodialysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SpO2 | Platelet transfusion (if ≤50,000/mm2) FFP /+ rFVIIa (if INR≥1.5) | I | II | III/IV | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
<80 | >80 | 2nd hourly monitoring in quiet environment in high dependency ward | ICU management Stat CT to R/O ICH Short acting BZD Lactulose | ICU management Intubation & mechanical ventilation Propofol Elevate head end to 30° Quiet environment monitoring for CVP, hemodynamic & renal parameters, serum electrolytes, acid base status & neurological status | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20% mannitol | No improvement | Hyperventillation | Worsening | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3% NS | Transfer to ICU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reduce core temperature to 32°-34° (monitor for arrhythmias) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thiopental 125 mg i.v bolus | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Improvement or refractory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transplantation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||